ARCHIVES

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

This article is from The Cancer Letter archive.

Vol. 12 No. 34 | August 22, 1986

Download PDF Visit The Full Archive

Related Articles

In Brief: NIH Call For Review Group Nominations Brings 8,000 Names For 400 Vacancies

August 17, 1979

Bush Proposes $27.9 Billion for NIH, Plus $1.4B Reprogram From FY03

February 7, 2003

Phase II Study Finds Dasatinib May Overcome ALL Resistance

May 25, 2007

SPOREs hammer out research agenda, seek $50,000 from NCI for further tissue analysis.

April 30, 2004

Tobacco Company Liggett Gave $3.6 Million To Henschke For CT Screening Research.

March 28, 2008

Majority Of Americans Support Cigarette Tax Increase, Survey Finds

May 28, 1993